
    
      This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Forty
      subjects were randomly divided into unripe Bokbunja extract 600 mg or placebo group. The
      investigators measured total cholesterol, lipid profile, arteriosclerosis index,
      anthropometric index, oxidized LDL.
    
  